Mwa Asset Management Vertex Pharmaceuticals Inc Transaction History
Mwa Asset Management
- $144 Billion
- Q1 2025
A detailed history of Mwa Asset Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mwa Asset Management holds 4,925 shares of VRTX stock, worth $2.2 Million. This represents 1.66% of its overall portfolio holdings.
Number of Shares
4,925
Previous 3,186
54.58%
Holding current value
$2.2 Million
Previous $1.28 Billion
86.1%
% of portfolio
1.66%
Previous 0.85%
Shares
7 transactions
Others Institutions Holding VRTX
# of Institutions
1,832Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.8 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.5 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.53 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.5 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.27 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $115B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...